HERTFORDSHIRE, England and PITTSBURGH, May 4, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that the Company will present at the Bank of America Merrill Lynch 19^th Annual Health Care Conference on Tuesday, May 10, 2016, in Las Vegas, NV. The presentation is scheduled to begin at 3:40 p.m. PDT / 6:40 p.m. EDT.

Interested parties can access a live webcast of the presentation via the investor relations section of Mylan's Web site at www.mylan.com/investors.  

About Mylan

Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,400 generic and branded pharmaceuticals, including antiretroviral therapies on which approximately 50% of people being treated for HIV/AIDS in the developing world depend. We market our products in approximately 165 countries and territories. Our global R&D and manufacturing platform includes more than 50 facilities, and we are one of the world's largest producers of active pharmaceutical ingredients. Every member of our nearly 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at mylan.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mylan-to-present-at-the-bank-of-america-merrill-lynch-19th-annual-health-care-conference-300262557.html

SOURCE Mylan N.V.